Abstract 2082: NMS-E668, a potent and selective RET kinase inhibitor characterized by specificity towards VEGFR2 and high antitumor efficacy against RET-driven modelsElena Ardini, Maria Menichincheri, Antonella Ermoli et al.|Cancer Research|2017Cited by 1
Abstract A213: Potent anticancer activity <i>in vitro</i> and <i>in vivo</i> by NMS-E973, a novel synthetic inhibitor of HSP90Gianpaolo Fogliatto, Antonella Isacchi, Sergio Mantegani et al.|Molecular Cancer Therapeutics|2009Cited by 0
Abstract 2522: Identification and characterization of new highly selective and potent BRAF inhibitorsMaurizio Pulici, Marina Ciomei, Nadia Amboldi et al.|Cancer Research|2010Cited by 0